The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Our vial-to-vein closed solutions offer cutting-edge, innovative protection for healthcare facilities and staff that reduces the risk of exposure and hazardous drug contamination while maintaining drug sterility.
The Chemfort® product family is designed and manufactured with a focus on safety, simplicity, and efficiency. Chemfort® has been tested with real cytotoxic drugs for vapor containment and found compatible with all known hazardous drugs. In addition, the product family has FDA and CE approval and is ONB compliant.
Simplivia’s portfolio includes the Chemfort® CSTD for drug preparation. Chemfort® is empowered by patented Toxi-Guard® technology and supported by 20 years of leading science and peer-reviewed studies. It also includes the Chemfort™ Closed Administration product family, offering complete integration with nurse workflows and drug protocols. The addition of the Administration portfolio enables a complete vial-to-vein solution that ensures the safety of healthcare professionals when handling hazardous drugs. At the same time, drug sterility is maintained.
Chemfort® provides pharmacists and nurses with unmatched safety and a confident experience when handling hazardous drugs.
For more information, please visit: https://www.simplivia.com/